Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Video Expert Opinion
Colleague Insights
Conferences
Sign in
Join now
story of the week
Published in Multiple Sclerosis and
1 other channel

Journal Scan / Research · June 02, 2021

NMOSD Biomarker: Serum Glial Fibrillary Acidic Protein

Annals of Neurology

 

 Save  Recommend
 Share

Additional Info

Disclosure statements are available on the authors' profiles:

Klemens Ruprecht MD

Patrick Schindler MD

Annals of Neurology
Serum Glial Fibrillary Acidic Protein: A Neuromyelitis Optica Spectrum Disorder Biomarker
Ann. Neurol 2021 May 01;89(5)895-910, O Aktas, MA Smith, WA Rees, JL Bennett, D She, E Katz, BAC Cree

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading

Most Read This Week

Recently Updated